Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
445 DKK | -5.32% | +17.41% | +256.00% |
07/05 | Gubra A/S Announces Management Changes | CI |
17/04 | Gubra Unveils UCN2 as Novel Anti-Obesity Drug Candidate for Healthy Weight Loss | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
104.05Cr | - | - | - | - | - | |
12TCr | ||||||
12TCr | ||||||
2.7TCr | - | |||||
2.04TCr | - | |||||
1.59TCr | - |
- Stock Market
- Equities
- GUBRA Stock
- Charts Gubra A/S
- Sector Chart